✦ LIBER ✦

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials

✍ Scribed by Iacovelli, Roberto; Alesini, Daniele; Palazzo, Antonella; Trenta, Patrizia; Santoni, Matteo; De Marchis, Laura; Cascinu, Stefano; Naso, Giuseppe; Cortesi, Enrico

Book ID: 121408493
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 747 KB
Volume: 40
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2013.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P040 Antiangiogenic targeted agents impr

P040 Antiangiogenic targeted agents improve overall survival in metastatic Renal Cell Carcinoma (mRCC). A meta-analysis of published trials

✍ Iacovelli, R.; Verzoni, E.; Palazzo, A.; Grassi, P.; Testa, I.; Cortesi, E.; Pro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Treatment Patterns: Targeted Therapies I

Treatment Patterns: Targeted Therapies Indicated for First-Line Management of Metastatic Renal Cell Carcinoma in a Real-World Setting

✍ Hess, Gregory; Borker, Rohit; Fonseca, Eileen 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 276 KB

Economic evaluation of new targeted ther

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Surrogate End Points and Postprogression

Surrogate End Points and Postprogression Survival in Renal Cell Carcinoma: An Analysis of First-Line Trials With Targeted Therapies

✍ Petrelli, Fausto; Barni, Sandro 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 625 KB

PCN62 Cost-Effectiveness Analysis of Fir

PCN62 Cost-Effectiveness Analysis of First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

✍ Nuñez, S.M.; Godoy, J.I.; Cardona, A.F.; Otero, J.M.; Lujan, M.; Lopera, D.; Car 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN10 Targeted Therapy (TT) for First Li

PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)

✍ Matheus, W.; Duran, M.A.; Clark, O.A.C.; Kumar, A.; Ferreira, U.; Botrel, T.E.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB